← Xtant Medical Holdings, Inc.

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net Income (Loss) Attributable to Parent ($19.5m) ($52.4m) ($70.1m) ($8.2m) ($7.0m) ($4.8m) ($8.5m) $660k ($16.4m) $5.0m
Depreciation, Depletion and Amortization $7.2m $8.4m $6.6m $3.1m $2.1m $1.3m $1.3m $3.2m $4.2m $5.2m
Depreciation $2.8m $3.8m $3.2m $3.1m $2.0m $1.3m $1.2m $1.8m $2.5m $3.6m
Amortization of Intangible Assets $4.5m $4.6m $2.5m $58k $100k $100k $100k $1.4m $1.7m $1.6m
Depreciation Expense $7.2m $8.4m $6.6m $3.1m $2.1m $1.3m $1.3m $3.2m $4.2m $5.2m
Deferred Income Tax Expense (Benefit) $0 $0 — — — — — ($1.9m) $21k ($38k)
Share-based Payment Arrangement, Noncash Expense $523k $212k $694k $515k $1.1m $2.2m $2.5m $2.7m $4.1m $2.9m
Share-based Payment Arrangement, Expense $488k $212k — — — — — — — —
Goodwill, Impairment Loss — — $38.3m — — — — — — —
Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) $0 — — — — — — — — —
Gain (Loss) on Disposition of Assets ($25k) ($10k) $103k ($61k) $369k $86k $93k $115k $264k ($251k)
Gain (Loss) on Disposition of Property Plant Equipment — ($21.2m) ($48.2m) $61k — — — — — —
Gain (Loss) on Extinguishment of Debt $0 — — ($1.5m) ($3.5m) — — — — —
Income Tax Expense (Benefit) $50k $0 — ($98k) $296k — $69k ($1.7m) $187k $2.0m
Interest Expense Nonoperating — — — — — — — — $4.2m $3.7m
Operating Lease, Expense — — — $588k $600k $600k $600k $700k $900k $1.2m
Other Nonoperating Income (Expense) ($352k) ($75k) $3k ($101k) — — — — ($33k) $73k
Changes in operating assets and liabilities:
Additional Financial Items
Increase (Decrease) in Accounts Receivable $2.7m ($4.7m) ($2.5m) $647k ($2.9m) $319k $3.9m $8.7m $755k $591k
Increase (Decrease) in Inventories $4.1m ($2.1m) ($40k) ($692k) $5.8m ($2.6m) $1.2m $1.9m $2.5m $2.0m
Increase (Decrease) in Accounts Payable $319k ($1.6m) ($3.0m) ($4.3m) $101k ($332k) $875k $3.0m $1.0m ($3.1m)
Proceeds from Stock Options Exercised $0 — — — — — — — $13k —
Foreign Currency Transaction Gain (Loss), Unrealized — — — — — — — $265k $5k ($60k)
General and Administrative Expense $15.8m $15.2m $12.9m $17.9m $13.5m $14.4m $15.5m $25.9m $28.7m $29.4m
Goodwill $41.5m $41.5m $3.2m $3.2m $3.2m $3.2m $3.2m $7.3m $7.3m $6.1m
Inventory Write-down — — — — — — $1.8m $357k $485k $3.7m
Investment Income, Interest — — — — — — $31k $149k — $94k
Nonoperating Income (Expense) ($11.9m) ($14.6m) ($10.0m) ($5.9m) ($6.0m) ($995k) ($1.7m) $9.1m ($4.2m) ($283k)
Operating Expenses $69.8m $87.9m $103.6m $44.8m $35.1m $36.3m $38.9m $65.6m $80.3m $77.0m
Payments of Financing Costs — — — — — $136k — — — —
Revenue from Contract with Customer, Including Assessed Tax — — $71.8m $64.5m — — — — — —
Stock or Unit Option Plan Expense — $127k — — — — — — — —
Non-cash interest $6.8m $14.7m $9.8m $5.7m $6.0m $147k $233k $386k $522k $537k
Loss (gain) on sale of fixed assets $25k $10k $103k ($61k) ($369k) ($86k) ($93k) ($115k) ($264k) $251k
Stock-based compensation $523k $212k $694k $515k $1.1m $2.2m $2.5m $2.7m $4.1m $2.9m
Provision for reserve on accounts receivable — — — — — — $243k $497k $823k $1.4m
Restructuring Expense — — — — — $839k $1.8m $357k $485k $3.7m
Other — — — — — — — $16k ($26k) ($76k)
Trade accounts receivable ($2.7m) $4.7m $2.5m ($647k) $2.9m ($319k) ($3.9m) ($8.7m) ($755k) ($591k)
Inventories ($4.1m) $2.1m $40k $692k ($5.8m) $2.6m ($1.2m) ($1.9m) ($2.5m) ($2.0m)
Prepaid and other assets ($484k) ($460k) $1.1m $204k $40k ($67k) $261k $220k ($218k) ($1.5m)
Accounts payable $319k ($1.6m) ($3.0m) ($4.3m) $101k ($332k) $875k $3.0m $1.0m ($3.1m)
Accrued liabilities ($2.1m) ($1.5m) $311k $1.5m ($512k) ($1.1m) $1.1m $3.8m ($2.9m) $4.2m
Proceeds from Sale of PP&E $16k $33k $257k $335k $241k $225k $205k $175k $383k $232k
Repayments on line of credit — — — — — ($36.5m) ($54.5m) ($77.0m) ($105.1m) ($101.3m)
Payments on financing leases — — — ($455k) ($156k) ($50k) ($50k) ($63k) ($65k) ($67k)
Proceeds from Stock Issuance $0 — — — — — — — $13k —
Derivative, Gain (Loss) on Derivative, Net $717k $203k $121k $3k — — — — — —
Gain (Loss) on Derivative Instruments, Net, Pretax $717k $203k — — — — — — — —
Net Cash Provided by (Used in) Operating Activities ($14.4m) ($543k) $1.2m ($413k) ($731k) $439k ($5.3m) ($9.5m) ($11.9m) $12.5m
Cash flows from investing activities:
Payments to Acquire Property, Plant, and Equipment ($5.8m) ($1.6m) $624k $879k $1.5m $2.1m $1.8m $1.5m $4.1m $2.4m
Payments to Acquire Businesses, Net of Cash Acquired — — — — — — — $4.5m — —
Payments to Acquire Investments — — — — — — — $17.0m — —
Net Cash Provided by (Used in) Investing Activities ($5.8m) ($1.6m) ($367k) ($544k) ($1.3m) ($1.9m) ($1.6m) ($24.8m) ($3.7m) $7.9m
Cash flows from financing activities:
Proceeds from Issuance of Long-term Debt — $12.8m — — — — — $4.8m $5.0m —
Proceeds from Debt Issuance — $12.8m — — — — — $4.8m $5.0m —
Debt issuance costs — — — — — — — ($239k) ($651k) ($49k)
Repayments of Long-term Debt $0 — — — $315k $411k — — — $8.0m
Payments on long-term debt $0 — — — ($315k) ($411k) — — — ($8.0m)
Proceeds from Issuance of Common Stock $0 — — — $620k $18.4m $9.3m $14.0m $13k —
Payment of taxes from withholding of common stock upon vesting and settlement of restricted stock units — — — — — ($201k) — ($261k) ($178k) ($126k)
Net Cash from Financing Activities $10.3m ($10.4m) $6.8m ($148k) — $36.4m $54.2m $78.2m $112.6m ($65k)
Net cash (used in) provided by financing activities $16.4m $2.4m $3.1m ($603k) ($861k) $17.5m $9.0m $19.7m $16.1m ($9.6m)
Net Cash Provided by (Used in) Financing Activities $16.4m $2.4m $3.1m ($603k) ($861k) $17.5m $9.0m $19.7m $16.1m ($9.6m)
Effect of Exchange Rate on Cash — — — — — — — $24k ($149k) $232k
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect — — — ($1.6m) ($2.9m) $16.0m $2.1m ($14.6m) $298k $11.1m
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents — — $3.9m ($1.6m) ($2.9m) $18.4m $20.5m $5.9m $6.2m $17.3m
Net change in cash and cash equivalents and restricted cash — — $3.9m ($1.6m) ($2.9m) $16.0m $2.1m ($14.6m) $298k $11.1m
Cash and cash equivalents and restricted cash at beginning of year — — $6.8m $5.2m $2.3m $18.4m $20.5m $5.9m $6.2m $17.3m
Cash and cash equivalents $2.6m $2.9m $6.8m — $2.3m $18.2m $20.3m $5.7m $6.2m $17.1m
Restricted cash — — — — — $144k $209k $208k $22k $275k
Total cash and cash equivalents and restricted cash reported in the consolidated balance sheets — — — — $2.3m $18.4m $20.5m $5.9m $6.2m $17.3m
Supplemental disclosure of cash flow information:
Interest Paid, Excluding Capitalized Interest, Operating Activities — $627k $186k $51k $13k $846k $1.5m $2.6m $3.6m $3.1m
Income Taxes Paid, Net — — — — — — — — — $121k

Data sourced from SEC EDGAR 10-K filings via EdgarTools. Amounts are shown in USD as reported in each fiscal year filing.